Prognostic impact of lymphadenectomy in clinically early stage malignant germ cell tumour of the ovary
Authors:
Open Access
- 19 July 2011
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 105 (4) , 493-497
Abstract
The aim of this study was to determine the impact of lymphadenectomy and nodal metastasis on survival in clinical stage I malignant ovarian germ cell tumour (OGCT). Data were obtained from the National Cancer Institute registry from 1988 to 2006. Analyses were performed using Student's t-test, Kaplan–Meier and Cox proportional hazard methods. In all, 1083 patients with OGCT who have undergone surgical treatment and deemed at time of the surgery to have disease clinically confined to the ovary were included 590 (54.48%) had no lymphadenectomy (LND−1) and 493 (45.52%) had lymphadenectomy. Of the 493 patients who had lymphadenectomy, 441 (89.5%) were FIGO surgical stage I (LND+1) and 52 (10.5%) were upstaged to FIGO stage IIIC due to nodal metastasis (LND+3C). The 5-year survival was 96.9% for LND−1, 97.7% for LND+1 and 93.4% for LND+3C (P=0.5). On multivariate analysis, lymphadenectomy was not an independent predictor of survival when controlling for age, histology and race (HR: 1.26, 95% CI: 0.62–2.58, P=0.5). Moreover, the presence of lymph node metastasis had no significant effect on survival (HR: 2.7, 95% CI: 0.67–10.96, P=0.16). Neither lymphadenectomy nor lymph node metastasis was an independent predictor of survival in patients with OGCT confined to the ovary. This probably reflects the highly chemosensitive nature of these tumours.Keywords
This publication has 29 references indexed in Scilit:
- The role of lymph node resection in ovarian cancer: analysis of the surveillance, epidemiology, and end results (SEER) databaseBJOG: An International Journal of Obstetrics & Gynaecology, 2010
- Racial disparities in surgical treatment and survival of epithelial ovarian cancer in United StatesJournal of Surgical Oncology, 2007
- Management of Ovarian Germ Cell TumorsJournal of Clinical Oncology, 2007
- Systematic Aortic and Pelvic Lymphadenectomy Versus Resection of Bulky Nodes Only in Optimally Debulked Advanced Ovarian Cancer: A Randomized Clinical TrialJNCI: Journal of the National Cancer Institute, 2005
- Treatment of ovarian germ cell tumors with a 3-day bleomycin, etoposide, and cisplatin regimen: a prospective multicenter studyGynecologic Oncology, 2004
- ACOG Committee Opinion Number 280: The Role of the Generalist Obstetrician-Gynecologist in the Early Detection of Ovarian CancerObstetrics & Gynecology, 2002
- Studying Radiation Therapy Using SEER-Medicare-Linked DataMedical Care, 2002
- Pattern of Lymph Node Metastases in Clinically Unilateral Stage I Invasive Epithelial Ovarian CarcinomasGynecologic Oncology, 2001
- Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patientsObstetrics & Gynecology, 1995
- Lymphadenectomy in stage I ovarian cancerAmerican Journal of Obstetrics and Gynecology, 1994